F32.3

Major depressive disorder, single episode, severe with psychotic features

## Overview of Major Depressive Disorder, Single Episode, Severe with Psychotic Features (F32.3) Major Depressive Disorder (MDD), Single Episode, Severe with Psychotic Features (ICD-10 F32.3) represents a profound and debilitating mental health condition characterized by a single, distinct episode of severe depression accompanied by psychotic symptoms. This diagnosis signifies a critical level of impairment, requiring immediate and often intensive clinical intervention. ### Pathophysiology The exact pathophysiology of MDD with psychotic features is complex and multifactorial, involving neurobiological, genetic, and environmental factors. Current theories suggest dysregulation of neurotransmitter systems, particularly serotonin, norepinephrine, and dopamine, plays a significant role. Brain imaging studies have shown structural and functional abnormalities in regions involved in mood regulation, executive function, and emotional processing, such as the prefrontal cortex, hippocampus, and amygdala. Hypothalamic-pituitary-adrenal (HPA) axis dysfunction, leading to elevated cortisol levels, is also commonly observed. Genetic predisposition contributes substantially, with higher rates among individuals with a family history of mood disorders or psychosis. The presence of psychotic features is often linked to more severe dopamine dysregulation, particularly in mesolimbic pathways, which is also implicated in other primary psychotic disorders. ### Clinical Presentation Individuals experiencing MDD, Single Episode, Severe with Psychotic Features present with the cardinal symptoms of a major depressive episode, intensified to a severe degree, alongside a distinct break from reality. Core depressive symptoms include a profoundly depressed mood nearly every day, pervasive anhedonia (loss of interest or pleasure in all or almost all activities), and significant functional impairment across all life domains. Vegetative symptoms are prominent and severe, encompassing marked changes in appetite (leading to significant weight loss or gain), severe sleep disturbances (insomnia or hypersomnia), psychomotor agitation (e.g., pacing, hand-wringing) or retardation (e.g., slowed speech, movements), overwhelming fatigue or loss of energy, and persistent feelings of worthlessness or excessive/inappropriate guilt. Concentration is severely impaired, and recurrent thoughts of death or suicidal ideation, often with specific plans or attempts, are common and represent a critical risk. The defining characteristic of F32.3 is the presence of psychotic features. These can include delusions and/or hallucinations. Delusions are fixed, false beliefs that are not amenable to change in light of conflicting evidence. In MDD with psychotic features, delusions are often mood-congruent, meaning their content is consistent with depressive themes (e.g., delusions of guilt, poverty, nihilism, catastrophic illness, or impending doom). For example, a patient might believe they are personally responsible for a major global disaster or that their internal organs are rotting. Less commonly, mood-incongruent delusions may occur, where the content is not typical of depression (e.g., delusions of grandiosity or bizarre persecutory delusions without a depressive theme). Hallucinations are sensory perceptions that occur without an external stimulus. Auditory hallucinations (e.g., hearing derogatory voices, voices telling them to harm themselves) are most common, but visual, tactile, or olfactory hallucinations can also occur. The presence of these psychotic symptoms indicates a severe disruption in reality testing and significantly increases the risk of self-harm or harm to others. ### Diagnostic Criteria (Adapted from DSM-5 for ICD-10 context) Diagnosis requires meeting criteria for a major depressive episode and specifiers for severity and psychotic features. At least five symptoms must be present during the same 2-week period and represent a change from previous functioning; at least one symptom must be either (1) depressed mood or (2) loss of interest or pleasure. These symptoms include: depressed mood, anhedonia, significant weight/appetite change, insomnia/hypersomnia, psychomotor agitation/retardation, fatigue/loss of energy, feelings of worthlessness/guilt, diminished concentration, and recurrent thoughts of death/suicidal ideation. The episode must cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. It must not be attributable to the physiological effects of a substance or another medical condition. Crucially, there must be no history of a manic or hypomanic episode (which would indicate bipolar disorder). The severity is classified as severe due to marked functional impairment and severe distress, and the presence of delusions or hallucinations confirms the 'with psychotic features' specifier. ### Standard of Care The standard of care for MDD, Single Episode, Severe with Psychotic Features often necessitates immediate and intensive intervention, frequently including hospitalization, especially due to high suicide risk and impaired judgment from psychosis. Pharmacotherapy is typically the first-line treatment, involving a combination of an antidepressant (e.g., SSRIs, SNRIs, tricyclic antidepressants, MAOIs) and an antipsychotic medication. The choice of medication depends on symptom profile, side effect susceptibility, and patient history. Electroconvulsive Therapy (ECT) is considered a highly effective and often rapid-acting treatment, particularly for severe depression with psychotic features, and may be a first-line option in cases of extreme severity, treatment resistance, or high suicide risk. Transcranial Magnetic Stimulation (TMS) may also be considered in some cases. Psychotherapy, such as Cognitive Behavioral Therapy (CBT) or Interpersonal Therapy (IPT), is typically initiated once acute psychotic symptoms are stabilized and the patient can engage meaningfully in therapy. Long-term management focuses on preventing relapse, managing residual symptoms, and addressing functional recovery. Close monitoring for suicidal ideation and adherence to treatment is paramount.

Clinical Symptoms

  • Persistent depressed mood nearly every day
  • Marked loss of interest or pleasure (anhedonia)
  • Significant weight loss or gain, or decrease/increase in appetite
  • Insomnia (difficulty sleeping) or hypersomnia (excessive sleeping)
  • Psychomotor agitation (e.g., restlessness, pacing) or retardation (e.g., slowed movements, speech)
  • Fatigue or loss of energy nearly every day
  • Feelings of worthlessness or excessive/inappropriate guilt
  • Diminished ability to think or concentrate, or indecisiveness
  • Recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan
  • Delusions (fixed, false beliefs, often mood-congruent e.g., guilt, nihilism, poverty, persecution, somatic concerns)
  • Hallucinations (sensory perceptions without external stimuli, e.g., auditory voices, visual disturbances)
  • Severe functional impairment in social, occupational, or other important areas
  • Impaired reality testing

Common Causes

  • Neurotransmitter imbalances (serotonin, norepinephrine, dopamine dysregulation)
  • Genetic predisposition and family history of mood disorders or psychosis
  • Hypothalamic-pituitary-adrenal (HPA) axis dysfunction and elevated cortisol
  • Structural or functional abnormalities in brain regions (e.g., prefrontal cortex, hippocampus, amygdala)
  • Severe psychosocial stressors (e.g., trauma, loss, chronic adversity)
  • Early childhood adversity or abuse
  • Certain medical conditions (e.g., neurological disorders, endocrine disorders, chronic illness)
  • Substance abuse or medication side effects (less common as primary cause, but can exacerbate)
  • Personality traits (e.g., neuroticism, low resilience)
  • Lack of social support or social isolation

Documentation & Coding Tips

Clearly differentiate 'single episode' from 'recurrent'. Documentation must explicitly state this is the patient's first major depressive episode meeting severe criteria with psychotic features.

Example: Patient is a 38-year-old female presenting with a primary complaint of persistent depressed mood, anhedonia, significant weight loss (15 lbs in 2 months), severe insomnia, and profound psychomotor retardation. Reports hearing 'voices' telling her she is worthless and should harm herself, which started 3 weeks ago. Family confirms no prior depressive or manic episodes. This is her *first documented Major Depressive Episode*.

Billing Focus: Specifying 'single episode' is crucial for correct F32.3 coding, distinguishing it from recurrent episodes (F33.x). Lack of this detail could lead to querying or incorrect coding for recurrent forms.

Document specific criteria for 'severe' episode. This includes at least five characteristic symptoms, with a clear impact on functional impairment (e.g., unable to work, self-care deficits).

Example: Patient endorses nearly daily depressed mood, markedly diminished interest in all activities, significant weight loss (15% body weight over 2 months) without dieting, insomnia (sleeping 2-3 hours/night), psychomotor agitation, profound fatigue, feelings of worthlessness/excessive guilt, inability to concentrate, and recurrent thoughts of death. He has been unable to leave his house or maintain personal hygiene for the past month, signifying *marked functional impairment*.

Billing Focus: Quantifiable symptoms (e.g., weight loss percentage, sleep hours) and explicit statements of functional impairment justify 'severe' classification, supporting higher E&M levels for complexity.

Describe the 'psychotic features' in detail, including whether they are mood-congruent or mood-incongruent, and their specific content (e.g., delusions of guilt, nihilism, poverty, somatic, or hallucinations).

Example: Patient reports *mood-congruent delusions* of extreme guilt, believing she is responsible for her family's financial struggles despite evidence to the contrary. Also reports *auditory hallucinations* where a voice (identifying as her deceased father) constantly criticizes her, reinforcing feelings of worthlessness and impending doom. These psychotic features are directly aligned with her pervasive depressive themes.

Billing Focus: Detailed description of psychotic features (type, content, mood congruence) provides critical specificity. Distinguishing mood-congruent from incongruent features is essential for accurate clinical picture and code justification.

Explicitly rule out substance-induced mood disorder or mood disorder due to another medical condition. Document negative screens or clinical assessment findings.

Example: Urine toxicology screen negative for illicit substances. Thyroid panel, B12, and folate levels within normal limits. Recent head CT negative for acute findings. Patient denies history of drug or alcohol abuse. No evidence of underlying medical condition explaining depressive symptoms or psychotic features.

Billing Focus: Ruling out other causes provides medical necessity for the psychiatric diagnosis and treatment, preventing potential denials or queries related to primary etiology.

Document the current treatment plan and initial response, particularly for acute management of severe symptoms and psychotic features (e.g., hospitalization, initiation of antipsychotics, ECT).

Example: Admitted for acute psychiatric stabilization due to severe suicidal ideation with plan. Initiated on Sertraline 50mg daily and Olanzapine 5mg nightly to target depressive symptoms and psychotic features. Patient shows minimal improvement in mood and psychotic thought content after 3 days. Considering ECT if no significant improvement in next 72 hours.

Billing Focus: Documentation of aggressive interventions (e.g., inpatient admission, specific psychotropic medications) supports the 'severe' nature of the illness and justifies the intensity of services provided.

Address safety concerns, especially suicidal ideation, and document risk assessment and mitigation strategies.

Example: Patient reports passive suicidal ideation ('I wish I weren't here') but denies active plan, intent, or access to means. Safety contract reviewed and signed with family involvement. Close follow-up arranged within 24 hours of discharge. Family instructed on warning signs and emergency protocols.

Billing Focus: Thorough documentation of suicide risk assessment and safety planning supports medical necessity for intensive outpatient follow-up or higher levels of care, preventing denials for services.

Relevant CPT Codes

Related Diagnoses

Hierarchy